Evidence map›Paper›PMID 38928454›Full record

ArticleInternational journal of molecular sciences2024

Extracellular Microenvironment Alterations in Ductal Carcinoma In Situ and Invasive Breast Cancer Pathologies by Multiplexed Spatial Proteomics.

Taylor S Hulahan, Laura Spruill, Elizabeth N Wallace, Yeonhee Park, Robert B West, Jeffrey R Marks, E Shelley Hwang, Richard R Drake, Peggi M Angel

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Special Issue: The Role of Extracellular Matrix Proteins in Pathogenesis.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Taylor S HulahanDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.
Laura SpruillDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Elizabeth N WallaceDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0001-7019-4187
Yeonhee ParkDepartment of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53726, USA.ORCID 0000-0001-9645-3407
Robert B WestDepartment of Pathology Clinical, Stanford University, Stanford, CA 94305, USA.
Jeffrey R MarksDepartment of Surgery, Duke University, Durham, NC 27710, USA.
E Shelley HwangDepartment of Surgery, Duke University, Durham, NC 27710, USA.
Richard R DrakeDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.
Peggi M AngelDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.ORCID 0000-0002-4436-555X

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
Orbitrap Fusion Lumos ETD Mass SpectrometerS10OD025126 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2018 to 2018
$991k
Orbitrap Mass SpectrometerS10OD010731 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2012 to 2012
$600k
NIH HHS 5T32 GM008716-24NIH HHS 5TL1TR001451-09NIH HHS P30 CA138313NIH/NCI RO1CA253460NIH/OD S100D030212NIH/OD S10OD010731NIH/OD S10OD025126
6 · The paper itself

Abstract

Ductal carcinoma in situ (DCIS) is a heterogeneous breast disease that remains challenging to treat due to its unpredictable progression to invasive breast cancer (IBC). Contemporary literature has become increasingly focused on extracellular matrix (ECM) alterations with breast cancer progression. However, the spatial regulation of the ECM proteome in DCIS has yet to be investigated in relation to IBC. We hypothesized that DCIS and IBC present distinct ECM proteomes that could discriminate between these pathologies. Tissue sections of pure DCIS, mixed DCIS-IBC, or pure IBC (

Indexed as

Breast NeoplasmsCarcinoma, Intraductal, NoninfiltratingExtracellular MatrixProteomicsTumor MicroenvironmentCarcinoma, Ductal, BreastFemaleHumansMiddle AgedNeoplasm InvasivenessProteomeProteomecollagenductal carcinoma in situ (DCIS)extracellular matrix (ECM)invasive breast cancer (IBC)invasive ductal carcinoma (IDC)matrix-assisted laser desorption/ionization–mass spectrometry imaging (MALDI-MSI)tumor microenvironment

Identifiers

PMID38928454
PMCPMC11203487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.